Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels

  • Ferre-Giraldo, Adriana
  • Castells-Esteve, Manel|||0000-0003-2370-2008
  • Sánchez Herrero, José Francisco|||0000-0001-6771-4807
  • López-Rodrigo, O.
  • De Rocco Ponce, Maurizio|||0000-0002-0821-3591
  • Bassas, Lluís|||0000-0002-3473-3611
  • Vigués, Francesc|||0000-0003-3717-6301
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Larriba, Sara|||0000-0003-4579-5452
PSA screening has led to an over-diagnosis of prostate cancer (PCa) and unnecessary biopsies of benign conditions due to its low cancer specificity. Consequently, more accurate, preferentially non-invasive, tests are needed. We aim to evaluate the potential of semen sEV (small extracellular vesicles) tsRNAs (tRNA-derived small RNAs) as PCa indicators. Initially, following a literature review in the OncotRF database and high-throughput small RNA-sequencing studies in PCa tissue together with the sncRNA profile in semen sEVs, we selected four candidate 5'tRF tsRNAs for validation as PCa biomarkers. RT-qPCR analysis in semen sEVs from men with moderately elevated serum PSA levels successfully shows that the differential expression of the four tRFs between PCa and healthy control groups can be detected in a non-invasive manner. The combined model incorporating PSA and specific tRFs (5'-tRNA-Glu-TTC-9-1_L30 and 5'-tRNA-Val-CAC-3-1_L30) achieved high predictive accuracy in identifying samples with a Gleason score ≥ 7 and staging disease beyond IIA, supporting that the 5'tRF fingerprint in semen sEV can improve the PSA predictive value to discriminate between malignant and indolent prostate conditions. The in silico study allowed us to map target genes for the four 5'tRFs possibly involved in PCa. Our findings highlight the synergistic use of multiple biomarkers as an efficient approach to improve PCa screening and prognosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A comprehensive study of common and rare genetic variants in spermatogenesis-related loci identifies new risk factors for idiopathic severe spermatogenic failure

  • Guzmán-Jiménez, Andrea|||0000-0002-2091-0568
  • González-Muñoz, Sara
  • Cerván-Martín, Miriam|||0000-0001-6033-0587
  • Garrido, Nicolás|||0000-0001-8271-5218
  • Castilla, José Antonio|||0000-0003-2185-565X
  • Gonzálvo, María Carmen
  • Clavero, Ana
  • Molina, Marta
  • Luján, Saturnino|||0000-0002-5005-3325
  • Santos-Ribeiro, Samuel|||0000-0003-2476-7858
  • Vilches, Miguel Angel|||0000-0002-5533-437X
  • Espuch, Andrea
  • Maldonado, Vicente|||0000-0003-4456-7191
  • Galiano-Gutiérrez, Noelia
  • Santamaría-López, Esther
  • González-Ravina, Cristina
  • Quintana-Ferraz, Fernando
  • Gómez, Susana
  • Amorós, David
  • Martínez-Granados, Luis
  • Ortega-González, Yanira
  • Burgos, Miguel|||0000-0003-4446-9313
  • Pereira-Caetano, Iris
  • Bulbul, Ozgur
  • Castellano, Stefano
  • Romano, Massimo
  • Albani, Elena
  • Bassas, Lluís|||0000-0002-3473-3611
  • Seixas, Susana|||0000-0002-7035-7422
  • Gonçalves, João|||0000-0001-9359-8774
  • Lopes, Alexandra M.|||0000-0003-3539-2318
  • Larriba, Sara|||0000-0003-4579-5452
  • Palomino-Morales, Rogelio J.|||0000-0003-3507-343X
  • Carmona, F. David|||0000-0002-1427-7639
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
STUDY QUESTION: Can genome-wide genotyping data be analysed using a hypothesis-driven approach to enhance the understanding of the genetic basis of severe spermatogenic failure (SPGF) in male infertility? SUMMARY ANSWER: Our findings revealed a significant association between SPGF and the SHOC1 gene and identified three novel genes (PCSK4, AP3B1, and DLK1) along with 32 potentially pathogenic rare variants in 30 genes that contribute to this condition. WHAT IS KNOWN ALREADY: SPGF is a major cause of male infertility, often with an unknown aetiology. SPGF can be due to either multifactorial causes, including both common genetic variants in multiple genes and environmental factors, or highly damaging rare variants. Next-generation sequencing methods are useful for identifying rare mutations that explain monogenic forms of SPGF. Genome-wide association studies (GWASs) have become essential approaches for deciphering the intricate genetic landscape of complex diseases, offering a cost-effective and rapid means to genotype millions of genetic variants. Novel methods have demonstrated that GWAS datasets can be used to infer rare coding variants that are causal for male infertility phenotypes. However, this approach has not been previously applied to characterize the genetic component of a whole case-control cohort. STUDY DESIGN, SIZE, DURATION: We employed a hypothesis-driven approach focusing on all genetic variation identified, using a GWAS platform and subsequent genotype imputation, encompassing over 20 million polymorphisms and a total of 1571 SPGF patients and 2431 controls. Both common (minor allele frequency, MAF.